For the Inventor, By the Inventor

Enter assignee name

Copenhagen, Denmark

Rigshospitalet

Calculating rank

USPTO Granted Patents = 19

% Expired Patents = 47.4

EPO Patents = 17

Forward Citations = 36

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Ib Jarle Christensen (5 out of 5 patents)

Hans Jørgen Nielsen (4 out of 4 patents)

Nils Aage Brünner (3 out of 5 patents)

4. Pär Ingemar Johansson (3 out of 5 patents)

5. Andreas Kjær (3 out of 4 patents)

6. Mads Nikolaj Holten-Andersen (3 out of 3 patents)

7. Andreas Kjaer (2 out of 11 patents)

8. Peter Garred (2 out of 8 patents)

9. Christoffer Nielsen (2 out of 2 patents)

10. Niels Behrendt (2 out of 2 patents)

11. Lars Henning Engelholm (2 out of 2 patents)

12. Stig Bojesen (2 out of 2 patents)

13. Børge Grønne Nordestgaard (2 out of 2 patents)

14. Ross W Stephens (2 out of 2 patents)

15. Julia S Johansen (2 out of 8 patents)

19 patents: Sort by Forward Citations

1. 12673926 - Tetrazine compounds for in vivo imaging (2026-07-07),

2. 12521454 - Ga- andCu-NODAGA-E[c(RGDyK)]for use as PET tracers in the imaging of angiogenesis in humans (2026-01-13),

3. 12433916 - Cell bank of high concentration adipose-derived stem cell composition and related methods (2025-10-07),

4. 12226495 - F-labeled novel tetrazines imaging probes for pretargeting in PET imaging (2025-02-18),

5. 11819552 - Antibody-drug conjugates targeting uPARAP (2023-11-21),

6. 11554261 - System for electrical stimulation during functional MRI (2023-01-17),

7. 10940213 - Antibody-drug conjugates targeting uPARAP (2021-03-09),

8. 10111969 - uPAR targeting peptide for use in peroperative optical imaging of invasive cancer (2018-10-30),

9. 9573984 - Chimeric inhibitor molecules of complement activation (2017-02-21),

10. 9433589 - Injectable pharmaceutical compositions comprising adrenaline and citric acid (2016-09-06),

11. 9381243 - Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof (2016-07-05),

12. 9381166 - Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength (2016-07-05),

13. 9012154 - Ficolin-3 assay (2015-04-21),

14. 8920775 - Loading technique for preparing radionuclide containing nanoparticles (2014-12-30),

15. 8697384 - YKL-40 as a general marker for non-specific disease (2014-04-15),

Company Overview

Rigshospitalet, located in Copenhagen, Denmark, is a leading university hospital renowned for its advanced medical research and specialized healthcare services. It focuses on a wide range of medical fields, including oncology, cardiology, and neurology, and is dedicated to integrating cutting-edge technology into patient care. The hospital plays a pivotal role in clinical trials and innovative treatment methodologies, contributing significantly to the advancement of medical science and improving patient outcomes both locally and internationally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#21 in Copenhagen

#153 in Denmark

#32,693 in the World

Copenhagen, Denmark

Rigshospitalet

Forward Citations = 36

54 inventors:

Ib Jarle Christensen (5 out of 5 patents)

Hans Jørgen Nielsen (4 out of 4 patents)

Nils Aage Brünner (3 out of 5 patents)

4. Pär Ingemar Johansson (3 out of 5 patents)

5. Andreas Kjær (3 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rigshospitalet. Retrieved from https://idiyas.com/company/rigshospitalet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…